雅虎香港 搜尋

登入

搜尋結果

  1. www.jnj.comJohnson & Johnson: Changing health for humanity

    1 天前 · With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.

    • Latest News

      A collection of stories that highlight the way Johnson ...

    • Innovation

      Meet Xiao-Yu Song, Global Head of Research & ...

    • Caring & Giving

      Melissa Martinez is a clinical scientist within Johnson ...

    • Personal Stories

      Nina Raver-Shapira, Ph.D., loves a challenge: The ...

    • Our Heritage

      For Women’s History Month, we’re ...

    • Suppliers

      As we advance our vision of a healthier world for all, ...

    • Careers

      Johnson & Johnson is an Affirmative Action and ...

    • Media Center

      2024 First-Quarter reported sales growth of 2.3% to ...

  2. www.jnj.com › corporate-reportsCorporate reports - Johnson & Johnson

    4 天前 · Corporate reports. Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

  3. 其他人也問了

  4. medicinetomarket.com › johnson-johnson-seeks-to-broaden-useJohnson & Johnson Seeks to Broaden Use of Prezcobix in ...

    4 天前 · In a significant move towards expanding treatment options for younger patients with HIV-1, Johnson & Johnson, through its Janssen Pharmaceutical

  5. www.careers.jnj.com › janssen-global-market-access-postGlobal Market Access Post-Doctoral Program | Johnson & ...

    5 天前 · The Global Market Access Post-Doctoral Program offers fellows in Global Market Access advanced training and mentorship to prepare them for success. The program is designed to harness the skills of candidates who are expected to receive or who have recently received a relevant doctoral degree in the last 12 months.

  6. www.pharmaceutical-technology.com › news › johnson-johnsonJohnson & Johnson seeks approvals for paediatric HIV-1 ...

    4 天前 · Johnson & Johnson (J&J) has filed a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking expanded approval for the use of its HIV-1 therapy, PREZCOBIX (darunavir/cobicistat), in children aged six years and above. Approval is being sought for PREZCOBIX use in paediatric patients weighing a minimum of 25kg.

  7. global.chinadaily.com.cn › a › 202112Janssen Pharmaceutical Companies sign MoU with Amoy Diagnostics

    4 天前 · The Janssen Pharmaceutical Companies of Johnson & Johnson signs an MoU on strategic collaboration with Amoy Diagnostics Co Ltd on Sunday to reinforce partnership with local diagnostic companies to build up a collaborative biopharmaceutical ecosystem to optimize drug life cycle and empower full-cycle patient management.

  8. www.janssenscience.com › products › xareltoXARELTO - Creatinine Clearance or Estimated Glomerular ...

    4 天前 · Estimated glomerular filtration rate (eGFR), creatinine clearance (CrCl), and serum creatinine (SrCr) are measures used to assess renal function. 1, 2 For the majority of patients, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula-derived eGFR, Modification of Diet in Renal Disease (MDRD) equation-derived eGFR, or ...